Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses:
Research and development expenses	$ 2,060,815	$ 1,834,371	$ 5,446,718	$ 4,751,308
General and administrative expenses	1,846,214	3,068,581	5,428,098	9,358,429
Lease termination costs	0	944,445	0	944,445
Total operating expenses	3,907,029	5,847,397	10,874,816	15,054,182
Loss from operations	(3,907,029)	(5,847,397)	(10,874,816)	(15,054,182)
Other income (expense):
Gain on bargain purchase upon merger	0	0	0	11,939,331
Interest income	1,207	95,787	54,242	294,694
Interest expense	0	0	0	(606)
Net loss	(3,905,822)	(5,751,610)	(10,820,574)	(2,820,763)
Comprehensive loss	$ (3,905,822)	$ (5,751,610)	$ (10,820,574)	$ (2,820,763)
Per share information:
Net loss per share, basic and diluted (in dollars per share)	$ (0.21)	$ (1.10)	$ (0.73)	$ (0.60)
Weighted average common shares outstanding basic and diluted (in shares)	18,961,619	5,246,829	14,892,764	4,729,153